Widén, Julia
Ivarsson, Magnus
Schalin, Lovisa
Vrouchou, Polina
Schwenkglenks, Matthias
Heimbürger, Olof
Ademi, Zanfina
Sutherland, C. Simone
Funding for this research was provided by:
Vifor Pharma
Article History
First Online: 2 April 2020
Compliance with Ethical Standards
:
: This study was funded by Vifor Pharma Ltd.
: Julia Widén received consultancy fees from Vifor Pharma Ltd. to complete the reported analysis. Polina Vrouchou, Lovisa Schalin and Magnus Ivarsson were employed by Vifor Pharma Ltd. or one of its subsidiaries at the time of the analysis. Dr. C. Simone Sutherland, Dr. Zanfina Ademi and Prof. Dr. Matthias Schwenkglenks have received funding from Vifor Pharma Ltd. to develop the model that was used in this analysis. Dr. Olof Heimbürger has received lecture honoraria from Adcock Ingram Intensive Care, Astra-Zeneca, Baxter, Fresenius and Vifor Pharma Ltd. He has also participated on advisory boards of Astra-Zeneca, Opterion, Vifor Pharma Ltd. and taken part in clinical trials with Astra-Zeneca, Bayer, Glaxo Smith Kline, Otsuka and Triomed.